Hepatitis Medicines Export to USA & Washington from India | City Drug House Exporters
Leading exporter of hepatitis medicines from India, serving clients across Washington and the USA. City Drug House ensures quality, affordability, and dependable pharmaceutical exports
Hepcinat LP is a prescription antiviral medication used to treat chronic (long-term) Hepatitis C virus (HCV) infection in adults and children 3 years and older. It is a fixed-dose combination of Ledipasvir (90 mg) and Sofosbuvir (400 mg) designed to stop the virus from multiplying, eventually clearing it from the bloodstream.
Therapeutic Uses & Efficacy
Primary Use: Specifically indicated for treating chronic HCV infections (often genotypes 1, 4, 5, and 6).
Viral Load Reduction: By combining an NS5A inhibitor (Ledipasvir) and a nucleotide analog polymerase inhibitor (Sofosbuvir), the medication targets the virus at multiple stages of replication, drastically lowering the viral load.
Cure/Remission: The ultimate therapeutic goal is a sustained virologic response (SVR), meaning the virus is completely eliminated from the body, which helps prevent long-term complications like liver cirrhosis or liver cancer.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Leading exporter of hepatitis medicines from India, serving clients across Washington and the USA. City Drug House ensures quality, affordability, and dependable pharmaceutical exports
Hepcinat LP is a prescription antiviral medication used to treat chronic (long-term) Hepatitis C virus (HCV) infection in adults and children 3 years and older. It is a fixed-dose combination of Ledipasvir (90 mg) and Sofosbuvir (400 mg) designed to stop the virus from multiplying, eventually clearing it from the bloodstream.
Therapeutic Uses & Efficacy
Primary Use: Specifically indicated for treating chronic HCV infections (often genotypes 1, 4, 5, and 6).
Viral Load Reduction: By combining an NS5A inhibitor (Ledipasvir) and a nucleotide analog polymerase inhibitor (Sofosbuvir), the medication targets the virus at multiple stages of replication, drastically lowering the viral load.
Cure/Remission: The ultimate therapeutic goal is a sustained virologic response (SVR), meaning the virus is completely eliminated from the body, which helps prevent long-term complications like liver cirrhosis or liver cancer.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
